News

Last month, during Cannes Lions, Netflix announced that its ad inventory will be available to buy programmatically via Yahoo ...
Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI). Its collaboration with ...
AI Impact Awards: Workplace Newsweek Illustration "Hybrid and remote work have become super noisy," Smita Hashim, head of product at Zoom, told Newsweek.
As Palantir stock (presumably) comes back to Earth, three magnificent growth and/or value stocks will have the opportunity to ...
The Hong Kong-listed firm is advancing its pipeline using an mRNA system it says can compete with the industry’s best.
US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...
Everest Medicines unveils breakthroughs in AI+mRNA platform, reinforces global leadership in next-gen mRNA innovation: Hong Kong Monday, July 7, 2025, 10:00 Hrs [IST] Everest Medi ...
The digital health market is welcoming new IPOs for the first time in years. Bankers and investors think these 9 startups ...
PhaseV, a leader in AI/ML-driven clinical development, today announced the appointment of Melanie Ivarsson OBE, PhD, to the company's scientific advisory board. A veteran drug development leader, Dr.
Though indexes have rebounded, the first half of the year has been rocky for investors. The market had to digest a variety of ...